Back to results
US 12,410,393 B2Granted
E. coli strains having an oxidative cytoplasm
AssigneeSutro Biopharma, Inc.
InventorDaniel Groff
Life of this patent
Estimating the term…
Abstract
This disclosure provides an E. coli strain, which lacks thioredoxin reductase activity encoded by trxB and thioredoxin 1 activity encoded by trxA, and glutathione reductase activity encoded by gor. Said E. coli strain expresses a mutated AhpC protein having glutathione reductase activity and a cytosolic prokaryotic disulfide isomerase. The E. coli strain has an oxidative cytosol and can be used to efficiently produce proteins having disulfide bonds.
Claims23
An E. coli strain, wherein:
- i) the strain lacks the activity of a thioredoxin reductase encoded by trxB due to genetic mutation of trxB;
- ii) the strain lacks the activity of a thioredoxin 1 encoded by trxA due to genetic mutation of trxA;
- iii) the strain lacks the activity of a glutathione reductase encoded by gor due to genetic mutation of gor;
- and
- iv) the strain expresses a mutated AhpC protein, wherein the mutated AhpC protein has glutathione reductase activity.
2 more elements
A method for expressing soluble, recombinant proteins of interest in E. coli bacterial strains comprising the steps of:
- culturing an E. coli bacterial strain comprising an oxidizing cytosol and an expression cassette for expressing a protein of interest under conditions that permit expression of the protein of interest as a soluble protein, wherein the strain:
- i) lacks thioredoxin reductase activity due to genetic mutation of trxB;
- ii) lacks thioredoxin 1 activity due to genetic mutation of trxA;
- iii) lacks the activity of a glutathione reductase encoded by gor due to genetic mutation of gor;
- and
- iv) expresses a mutated AhpC protein, wherein the mutated AhpC protein has glutathione reductase activity.
3 more elements
Dependencies are inferred from the claim text.